Physician

Arunava D Ray, M.D.

According to 2025 Medicare claims, Arunava Ray, M.D. (NPI: 1568465094) practices cardiology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is AMARILLO HEART INSTITUTE, LLP (NPI: 1295448710; TIN: 883862154) and primary practice location at 79124-2193. Ray is affiliated with the Texoma Clinical Partners ACO, LLC (ACO ID: A4585), Caravan Health ACO 43 LLC (ACO ID: A4974), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Ray's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,229 traditional Medicare patients, billed 9,106 HCPCS/CPT codes, and received $1,106,345 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 15,330 prescription claims across 1,004 beneficiaries totaling $1,471,734 in drug costs, led by Eliquis (Apixaban). DME data shows 13 claims. Open Payments data shows 60 records totaling $2,215. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $641,036 to $1,471,734. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $14,145 to $34,528.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,169	17,647	$701,876
2016	3,334	17,663	$703,661
2017	3,345	16,907	$746,760
2018	3,727	20,615	$826,489
2019	3,631	22,371	$990,999
2020	2,972	17,987	$806,538
2021	2,581	17,924	$846,593
2022	2,328	14,122	$941,302
2023	2,324	11,570	$878,094
2024	2,229	9,106	$1,106,345

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	681	13,259	$641,036
2016	672	13,362	$656,893
2017	723	12,407	$582,995
2018	817	13,294	$718,906
2019	928	15,232	$906,210
2020	943	16,231	$1,042,644
2021	938	15,719	$1,084,201
2022	1,006	15,757	$1,220,470
2023	1,004	15,765	$1,551,488
2024	1,004	15,330	$1,471,734

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$119
2016	N/R	N/R	N/R
2017	N/R	17	$33,924
2018	N/R	N/R	N/R
2019	N/R	33	$69,901
2020	N/R	15	$33,141
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	13	$32,919

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	385	393	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	561	968	$87
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	568	848	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	673	876	$6
J2785	Injection, regadenoson, 0.1 mg	278	1,112	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	451	22,298	$426,287
Farxiga	Dapagliflozin Propanediol	266	12,959	$236,741
Xarelto	Rivaroxaban	309	12,918	$236,275
Entresto	Sacubitril/Valsartan	172	8,473	$181,358
Jardiance	Empagliflozin	61	2,820	$49,408

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	13	$32,919

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	60	$2,215	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arunava D. Ray, M.D.?

Tedicare shows public-source Medicare data for Arunava D. Ray, M.D. (NPI 1568465094), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arunava D. Ray, M.D. have ACO affiliation data?

Arunava D. Ray, M.D. is shown with ACO affiliation data for Texoma Clinical Partners ACO, LLC (MSSP, ACO ID A4585), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Arunava D. Ray, M.D.?

Arunava D. Ray, M.D. is linked to AMARILLO HEART INSTITUTE, LLP (billing NPI 1295448710) in the available physician profile data.

Does Arunava D. Ray, M.D. have Open Payments data?

Arunava D. Ray, M.D. has 60 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.